Evidence map›Paper›PMID 22266656›Full record

ArticleNucleic acids research2012

MATS: a Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data.

Shihao Shen, Juw Won Park, Jian Huang, Kimberly A Dittmar, Zhi-xiang Lu, Qing Zhou, Russ P Carstens, Yi Xing

Abstract readValidation Study
In one paragraph

Article in Nucleic acids research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 229 papers.

0numbers the graph read from it
0cells of the map it votes in
229citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

229 citing papers in PubMed.

  1. Article
  2. SRSF3 plays a key role in liver cancer sex disparity by facilitating hepatocyte expression of ERα and FOXA.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Viral Modulation of Host Splicing.Annual review of virology · 2025
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

169 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shihao ShenDepartment of Biostatistics, University of Iowa, Iowa City, IA 52242, USA.
Juw Won Park
Jian Huang
Kimberly A Dittmar
Zhi-xiang Lu
Qing Zhou
Russ P Carstens
Yi Xing

Funding

UNIVERSITY OF IOWA CTSA FOR PEDIATRIC RESEARCHUL1RR024979 · NCRR · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2007 to 2011
$31.8M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Multidisciplinary Lung Research Career Development ProgramT32HL007638 · NHLBI · UNIVERSITY OF IOWA · PI WELSH, MICHAEL J., ZABNER, JOSEPH · 1986 to 2020
$16.9M
VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMESR01GM088342 · NIGMS · UNIVERSITY OF IOWA · PI XING, YI · 2010 to 2020
$2.9M
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMTR01GM088809 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI CARSTENS, RUSS PAUL · 2009 to 2013
$1.5M
Regularized Classification & Survival Analysis for Expression Profiling of CancerR01CA120988 · NCI · UNIVERSITY OF IOWA · PI HUANG, JIAN · 2008 to 2011
$1.2M
NCI NIH HHS R01CA120988NCRR NIH HHS UL1 RR024979NCRR NIH HHS UL1RR024979NHLBI NIH HHS T32HL007638NIDDK NIH HHS P30 DK054759NIDDK NIH HHS P30DK054759NIGMS NIH HHS R01 GM088342NIGMS NIH HHS R01GM088342NIGMS NIH HHS R01GM088809
6 · The paper itself

Abstract

Ultra-deep RNA sequencing has become a powerful approach for genome-wide analysis of pre-mRNA alternative splicing. We develop MATS (multivariate analysis of transcript splicing), a bayesian statistical framework for flexible hypothesis testing of differential alternative splicing patterns on RNA-Seq data. MATS uses a multivariate uniform prior to model the between-sample correlation in exon splicing patterns, and a Markov chain Monte Carlo (MCMC) method coupled with a simulation-based adaptive sampling procedure to calculate the P-value and false discovery rate (FDR) of differential alternative splicing. Importantly, the MATS approach is applicable to almost any type of null hypotheses of interest, providing the flexibility to identify differential alternative splicing events that match a given user-defined pattern. We evaluated the performance of MATS using simulated and real RNA-Seq data sets. In the RNA-Seq analysis of alternative splicing events regulated by the epithelial-specific splicing factor ESRP1, we obtained a high RT-PCR validation rate of 86% for differential exon skipping events with a MATS FDR of <10%. Additionally, over the full list of RT-PCR tested exons, the MATS FDR estimates matched well with the experimental validation rate. Our results demonstrate that MATS is an effective and flexible approach for detecting differential alternative splicing from RNA-Seq data.

Indexed as

Alternative SplicingHigh-Throughput Nucleotide SequencingSequence Analysis, RNABayes TheoremBrainCell Line, TumorHumansMultivariate AnalysisReverse Transcriptase Polymerase Chain ReactionRNA-Binding ProteinsRNA-Binding Proteins

Identifiers

PMID22266656
PMCPMC3333886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.